» Articles » PMID: 29201902

Studies on the Influence of Bacteriophage Preparations on the Autoimmune Inflammatory Process

Abstract

Phage preparations used for phage therapy may have not only direct antibacterial action but also immunomodulating effects mediated by phages themselves as well as by bacterial antigens. Therefore phage application in patients with immune disorders, and especially with autoimmune diseases, requires special attention. The aim of this study was to investigate the effect of phage lysates (staphylococcal phages A3/R, phi200, and MS-1 cocktail, enterococcal phage 15/P, phage 119x, and T4 phage) as well as purified T4 phage on the course of murine collagen-induced arthritis (CIA), commonly used as an animal model of rheumatoid arthritis. Intraperitoneal application of phage lysates or purified T4 phage did not aggravate the course of autoimmune joint disease. Moreover, although endotoxins are known to potentiate CIA, the systemic administration of phage lysate of , which contains debris of this Gram-negative bacillus, did not significantly influence CIA although the sonicate of the corresponding bacterial strain did. Interestingly, a purified T4 phage revealed some anti-inflammatory activity when applied under the therapeutic scheme. Our preliminary results do not suggest that phages may aggravate the symptoms of rheumatoid arthritis. In contrast T4 phage may even exert an immunosuppressive effect.

Citing Articles

Advancing Phage Therapy: A Comprehensive Review of the Safety, Efficacy, and Future Prospects for the Targeted Treatment of Bacterial Infections.

Palma M, Qi B Infect Dis Rep. 2024; 16(6):1127-1181.

PMID: 39728014 PMC: 11675988. DOI: 10.3390/idr16060092.


Delirium is not dementia: Delirium Awareness Day-related event at the University Hospital in Krakow.

Wieczorek-Stawinska W, Rys M, Perera I, Rudzinska A, Gryglewska B, Gasowski J Eur Geriatr Med. 2024; 15(2):407-410.

PMID: 38316720 DOI: 10.1007/s41999-023-00924-5.


Virome in immunodeficiency: what we know currently.

Wang H, Xu S, Li S, Su B, Sherrill-Mix S, Liang G Chin Med J (Engl). 2023; 136(22):2647-2657.

PMID: 37914672 PMC: 10684123. DOI: 10.1097/CM9.0000000000002899.


Bacteriophages as Potential Clinical Immune Modulators.

Souza E, Pinto A, Fongaro G Microorganisms. 2023; 11(9).

PMID: 37764066 PMC: 10535580. DOI: 10.3390/microorganisms11092222.


Sjögren's Syndrome Treatments in the Microbiome Era.

Freguia C, Pascual D, Fanger G Adv Geriatr Med Res. 2023; 5(2).

PMID: 37323129 PMC: 10270702. DOI: 10.20900/agmr20230004.


References
1.
Caccese R, Zimmerman J, Carlson R . Bacterial lipopolysaccharide potentiates type II collagen-induced arthritis in mice. Mediators Inflamm. 1992; 1(4):273-9. PMC: 2365350. DOI: 10.1155/S0962935192000425. View

2.
Miedzybrodzki R, Borysowski J, Weber-Dabrowska B, Fortuna W, Letkiewicz S, Szufnarowski K . Clinical aspects of phage therapy. Adv Virus Res. 2012; 83:73-121. DOI: 10.1016/B978-0-12-394438-2.00003-7. View

3.
Kingwell K . Bacteriophage therapies re-enter clinical trials. Nat Rev Drug Discov. 2015; 14(8):515-6. DOI: 10.1038/nrd4695. View

4.
Lusiak-Szelachowska M, Zaczek M, Weber-Dabrowska B, Miedzybrodzki R, Klak M, Fortuna W . Phage neutralization by sera of patients receiving phage therapy. Viral Immunol. 2014; 27(6):295-304. PMC: 4076984. DOI: 10.1089/vim.2013.0128. View

5.
Suszko A, Obminska-Mrukowicz B . Influence of polysaccharide fractions isolated from Caltha palustris L. on the cellular immune response in collagen-induced arthritis (CIA) in mice. A comparison with methotrexate. J Ethnopharmacol. 2012; 145(1):109-17. DOI: 10.1016/j.jep.2012.10.038. View